Atlas Trials

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Clinical trial NCT02575508 · WITHDRAWN

Trial details

NCT number
NCT02575508
Sponsor
Roswell Park Cancer Institute
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colon AdenocarcinomaMetastatic Pancreatic AdenocarcinomaPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaRectal AdenocarcinomaStage III Pancreatic CancerStage IIIA Colon CancerStage IIIA Rectal CancerStage IIIB Colon CancerStage IIIB Rectal CancerStage IIIC Colon CancerStage IIIC Rectal Cancer
Primary completion
2020-05-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.